Common issues in the management of patients in the waiting list and after liver transplantation

Dig Liver Dis. 2017 Mar;49(3):241-253. doi: 10.1016/j.dld.2016.12.027. Epub 2016 Dec 31.

Abstract

The present document contains the recommendations of an expert panel of transplant hepatologists, appointed by the Italian Association for the Study of the Liver (AISF), on how to manage the most common aspects of liver transplantation: the topics covered include: new treatments for HCV in patients on the waiting list for liver transplantation; antiviral treatments in patients with HCV recurrence after liver transplantation; prophylaxis for HBV recurrence after liver transplantation; indications for liver transplantation in alcoholic liver disease; and Immunosuppressive therapy. The statements on each topic were approved by participants at the AISF Transplant Hepatologist Expert Meeting (organized by the Permanent Committee on Liver Transplantation in Mondello on 4-5 October 2015), and are graded according to the Oxford classification of levels of evidence.

Keywords: Alcoholic liver disease; DAAs; HBV recurrence; Immunosuppression; Liver transplantation.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Disease Management*
  • Hepatitis C, Chronic / surgery
  • Hepatitis C, Chronic / therapy*
  • Humans
  • Italy
  • Liver Diseases, Alcoholic / complications*
  • Liver Diseases, Alcoholic / surgery
  • Liver Transplantation*
  • Recurrence
  • Societies, Medical
  • Waiting Lists*

Substances

  • Antiviral Agents